Neuphoria Therapeutics (BNOXN) Cash flow

0 Followers

Neuphoria Therapeutics Cash Flow

MX:BNOXN's free cash flow for Q4 2026 was AU$-12.34B. For the 2026 fiscal year, MX:BNOXN's free cash flow was decreased by AU$-12.43B and operating cash flow was AU$-12.34B. See a summary of the company’s cash flow.

Cash Flow	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Operating Cash Flow	$ -12.35B	$ 77.23M	$ -14.68M	AU$ -9.85M	AU$ -21.75M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	AU$ 0.00	AU$ 621.64K
Financing Cash Flow	$ 17.92B	$ 1.53B	$ 15.11M	AU$ 5.81M	AU$ 26.99M
End Cash Position	$ 19.87B	$ 14.29B	$ 12.69M	AU$ 8.06M	AU$ 33.56M
Free Cash Flow	$ -12.35B	$ 77.23M	$ -14.68M	AU$ -9.85M	AU$ -21.75M